Close

Intellipharmaceutics (IPCI) Announces $1.8 Million Registered Direct Offering

March 19, 2018 2:57 PM EDT Send to a Friend
Intellipharmaceutics International Inc. (NASDAQ: IPCI), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login